VORICONAZOLE — all Canadian products
27 DINs
18 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is VORICONAZOLE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02451387 | AURO-VORICONAZOLE | AURO PHARMA INC | Tablet | Oral | VORICONAZOLE 50 MG | Approved | |
| 02451395 | AURO-VORICONAZOLE | AURO PHARMA INC | Tablet | Oral | VORICONAZOLE 200 MG | Approved | |
| 02525798 | JAMP VORICONAZOLE | JAMP PHARMA CORPORATION | Tablet | Oral | VORICONAZOLE 200 MG | Marketed | |
| 02525771 | JAMP VORICONAZOLE | JAMP PHARMA CORPORATION | Tablet | Oral | VORICONAZOLE 50 MG | Marketed | |
| 02457709 | MED-VORICONAZOLE | GENERIC MEDICAL PARTNERS INC | Tablet | Oral | VORICONAZOLE 200 MG | Approved | |
| 02399245 | SANDOZ VORICONAZOLE | SANDOZ CANADA INCORPORATED | Tablet | Oral | VORICONAZOLE 50 MG | Marketed | |
| 02399253 | SANDOZ VORICONAZOLE | SANDOZ CANADA INCORPORATED | Tablet | Oral | VORICONAZOLE 200 MG | Marketed | |
| 02256460 | VFEND | PFIZER CANADA ULC | Tablet | Oral | VORICONAZOLE 50 MG | Marketed | |
| 02256479 | VFEND | PFIZER CANADA ULC | Tablet | Oral | VORICONAZOLE 200 MG | Marketed | |
| 02279991 | VFEND | PFIZER CANADA ULC | Powder For Suspension | Oral | VORICONAZOLE 200 MG | Marketed | |
| 02256487 | VFEND | PFIZER CANADA ULC | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Marketed | |
| 02544350 | VORICONAZOLE FOR INJECTION | FORMATIVE PHARMA INC. | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Approved | |
| 02381966 | VORICONAZOLE FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Marketed | |
| 02467852 | VORICONAZOLE FOR INJECTION | PHARMARIS CANADA INC | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Approved | |
| 02477696 | VORICONAZOLE FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Marketed | |
| 02486695 | VORICONAZOLE FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Approved | |
| 02493829 | VORICONAZOLE FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Marketed | |
| 02542994 | VORICONAZOLE FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Approved | |
| 02431998 | ACH-VORICONAZOLE | ACCORD HEALTHCARE INC | Tablet | Oral | VORICONAZOLE 50 MG | Cancelled Pre Market | |
| 02432005 | ACH-VORICONAZOLE | ACCORD HEALTHCARE INC | Tablet | Oral | VORICONAZOLE 200 MG | Cancelled Pre Market | |
| 02409674 | APO-VORICONAZOLE | APOTEX INC | Tablet | Oral | VORICONAZOLE 50 MG | Dormant | |
| 02409682 | APO-VORICONAZOLE | APOTEX INC | Tablet | Oral | VORICONAZOLE 200 MG | Dormant | |
| 02399962 | MYLAN-VORICONAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | VORICONAZOLE 50 MG | Cancelled Pre Market | |
| 02399989 | MYLAN-VORICONAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | VORICONAZOLE 200 MG | Cancelled Pre Market | |
| 02436353 | PMS-VORICONAZOLE | PHARMASCIENCE INC | Powder For Solution | Intravenous | VORICONAZOLE 200 MG | Cancelled Pre Market | |
| 02396866 | TEVA-VORICONAZOLE | TEVA CANADA LIMITED | Tablet | Oral | VORICONAZOLE 50 MG | Cancelled Post Market | |
| 02396874 | TEVA-VORICONAZOLE | TEVA CANADA LIMITED | Tablet | Oral | VORICONAZOLE 200 MG | Cancelled Post Market |
Browse other molecules: